TUCSON, Ariz., Nov. 27, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an innovator of rapid in vitro diagnostics in microbiology, announced the signing of a collaboration and ...
TUCSON, Ariz., Jan. 7, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) (Accelerate), an in vitro diagnostics company dedicated to providing services that improve patient outcomes and ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Accelerate Diagnostics has filed ...
TUCSON, Ariz., July 27, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX) announced today that management will host a conference call on Thursday, August 10, 2023, at 4:30 p.m. Eastern Time to ...
TUCSON, Ariz., Aug. 18, 2022 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) ("Accelerate Diagnostics") today announced the pricing of an underwritten public offering of 17,500,000 shares ...
BD (Becton, Dickinson and Co.) announced Aug. 15 a commercial collaboration under which the Franklin Lakes-based company will offer Accelerate Diagnostics Inc.’s rapid tests through its global sales ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Accelerate Diagnostics is ...
Operator: Good day, and welcome to the Accelerate Diagnostics Inc. Third Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Today’s remarks ...
TUCSON, Ariz., March 7, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX) announced today that management will host a conference call on Thursday, March 28, 2024, at 4:30 p.m. Eastern Time to ...
Accelerate Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.17 EPS, expectations were $-0.14. Operator: Good day, and welcome to the Accelerate Diagnostics Incorporated 2023 Q1 ...